After treatment, the peritoneal spread of the ovarian cancer mouse model was significantly inhibited, and extracellular regulated protein kinases (ERK) phosphorylation and matrix metallopeptidase 2 (MMP2) expression in tumors were reduced. The gene discussed is MMP2; the disease is ovarian cancer.